Found 5 matching trials
Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 PHASE2 This clinical trial will examine if a new treatment of Mesenchymal-like Adh...
Show More Location
University of California Irvine
Learn More & Join Trial
Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery PHASE1 This clinical trial is designed to evaluate KELI-101 versus placebo for the...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia PHASE1 The The purpose of this study is to determine the safety of PLX-PAD single ...
Show More Location
Franziskus-Krankenhaus
Learn More & Join Trial
Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) PHASE2 The objective of the study is to establish the safety profile of
Intramusc...
Show More Location
Cardiology, P. C. and Center for Therapeutic Angiogenesis
Learn More & Join Trial
Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI) PHASE1 The purpose of this study is to determine the safety of PLX-PAD, Intra-musc...
Show More Learn More & Join Trial